UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 14, 2006
INCYTE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
| 0-27488 |
| 94-3136539 |
(State or Other Jurisdiction of |
| (Commission File Number) |
| (I.R.S. Employer |
|
|
|
|
|
Experimental Station, Route |
| 19880 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
|
|
|
|
|
(302) 498-6700
(Registrant’s telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.
On March 14, 2006, Dr. Frederick B. Craves notified Incyte Corporation (the “Company”) that he would be retiring from the Board of Directors, effective at the time of the Company’s 2006 Annual Meeting of Stockholders, and therefore would not stand for re-election. Dr. Craves has been a member of the Company’s Board of Directors since 1993.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 16, 2006 |
| |||
|
| |||
| INCYTE CORPORATION | |||
|
| |||
|
| |||
| By: | /s/ Patricia A. Schreck |
| |
| Patricia A. Schreck |
| ||
| Executive Vice President and |
| ||
| General Counsel |
| ||
3